The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy

TY - JOUR

T1 - The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy

AU - Ueberroth, Benjamin E.

AU - Lawhorn-Crews, Jawana M.

AU - Heilbrun, Lance K.

AU - Smith, Daryn W.

AU - Akoury, Janice

AU - Ali-Fehmi, Rouba

AU - Eiseler, Nicole T.

AU - Eiseler, Nicole T.

AU - Shields, Anthony F.

N1 - Benjamin E. Ueberroth Jawana M. Lawhorn-Crews Lance K. Heilbrun Daryn W. Smith Janice Akoury Rouba Ali-Fehmi Nicole T. Eiseler Anthony F. Shields To assess the role of serial FLT-PET scans during early neoadjuvant treatment as a prognostic marker of response to treatment and survival.

PY - 2019/6/1

Y1 - 2019/6/1

UR - https://link.springer.com/article/10.1007%2Fs12149-019-01345-w

U2 - 10.1007/s12149-019-01345-w

DO - 10.1007/s12149-019-01345-w

M3 - Article

VL - 33

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

ER -